The SELUTION DeNovo Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

3,326

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

September 15, 2025

Study Completion Date

October 31, 2030

Conditions
Coronary Artery Disease
Interventions
DEVICE

SELUTION SLR

Patients randomized to the SELUTION SLR™ DEB arm will receive lesion preparation according to the 3rd DCB consensus (optimal balloon angioplasty with adjunct treatment using high-pressure balloon, shockwave, rotational atherectomy or cutting or scoring balloon at the discretion of the operator when necessary to maximize lumen diameter). Patients with lesions that are then best treated by provisional stenting (flow-limiting dissection, residual stenosis \> 30% or FFR \< 0.8) before or after use of DEB will receive a DES but remain in the SELUTION SLR™ DEB group (intention to treat analysis).

DEVICE

DES

For patients randomized to the DES strategy, all target lesions should be treated with DES, but use of a SELUTION SLR™ DEB or any other device is acceptable if a DES cannot be delivered to the target lesion. For bifurcation lesions, if the side-branch requires treatment it should be treated with another DES or with POBA, at the discretion of the operator, but not with a DEB.

Trial Locations (62)

Unknown

Academic Teaching Hospital Feldkirch, Feldkirch

University Heart Center Graz, Graz

Kepler Universitätsklinikum GmbH, Linz

University Hospital Brno, Brno

University Hospital Ostrava, Ostrava

SIUN sote Hospital and Healthcare center, Joensuu

CH La Rochelle, La Rochelle

Hôpital Jaques Cartier, Massy

CHU de Nîmes, Nîmes

Hôpital Européen Georges Pompidou, Paris

Centre Hospitalier de Pau, Pau

Clinique Saint Hilaire, Rouen

Universitätsklinik Augsburg, Augsburg

Universitätsklinikum Freiburg, Bad Krozingen

BG Klinikum Unfallkrankenhaus Berlin, Berlin

Charite Campus Virchow Klinikum, Berlin

Kardiologisch-Angiologische Praxis • Herzzentrum Bremen, Bremen

RKH Kliniken Bruchsal Fürst Stirum Klinik, Bruchsal

University Koeln, Cologne

Herzzentrum Dresden GmbH Universitätsklinik, Dresden

Elisabeth-Krankenhaus, Essen

Asklepios Kliniken GmbH & Co., Hamburg

University Medical Center Hamburg Eppendorf, Hamburg

MEDICLIN Herzzentrum Lahr, Lahr

Johannes Wesling Klinikum Minden, Minden

Herzklinikum Ulm, Ulm

Ospedale Civile Santi Antonio e Biagio e Cesare Arrigo, Alessandria

Clinica Mediterranea, Napoli

Ospedale Santa Croce di Moncalieri, Torino

Ospedale Sant'andrea, Vercelli

University Medical Center Amsterdam, Amsterdam

University Medical Center Groningen, Groningen

Tergooi MC, Hilversum

UMC Utrecht, Utrecht

Szpital Kliniczny Przemienienia Pańskiego UM, Poznan

Kliniczny Szpital Wojewódzki Nr. 2 w Rzeszowie, Rzeszów

Szpital Ministerstwa Spraw Wewnetrznych, Rzeszów

National Heart Centre Singapore (NHCS), Singapore

SengKang General Hospital, Singapore

Hospital Clinico de Barcelona, Barcelona

Hospital Universitario de La Princesa, Madrid

Hospital Alvaro Cunqueiro, University Hospital of Vigo, Vigo

University Hospital Geneva (HUG), Geneva

University Hospital Basel, Basel

University Hospital of Bern, Bern

Hôpital Cantonal de Fribourg, Fribourg

HOCH Health Ostschweiz Kantonsspital St.Gallen, Sankt Gallen

University Zurich, Zurich

The Royal Bournemouth and Christchurch Hospitals, Bournemouth

Royal Sussex County Hospital, Brighton

University Hospitals Bristol, Bristol

Royal Infirmary of Edinburgh, Edinburgh

Golden Jubilee National Hospital, Glasgow

Glenfield Hospital, Leicester

Manchester University NHS Foundation Trust, Manchester

Norfolk and Norwich University Hospitals, Norwich

Trent Cardiac Centre, Nottingham City Hospital, Nottingham

Royal Berkshire Hospital, Reading

Northern General, Sheffield, Sheffield

University Hospital Southampton, Southampton

Worcestershire Royal Hospital, Worcester

ST4 6QG

University Hospitals of North Midlands, Royal Stoke University Hospital, Stoke-on-Trent

All Listed Sponsors
lead

M.A. Med Alliance S.A.

INDUSTRY